Tulsi Therapeutics
PrivateLast Round
Grant
Jun 1, 2022
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Tulsi Therapeutics is a biotechnology company that specializes in the research, development, and manufacturing of stem cell and exosome-based regenerative medicine products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tulsi Therapeutics Comparables
Compare Tulsi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HepaTx Corporation | 80% | |
| Morphocell Technologies | 77% | |
| Stempeutics Research | 64% |
Tulsi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 |
Tulsi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| ASPIRE-BioNEST | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 42% QoQ, from 12 to 17 employees.
- May 22, 2026
Grew 33% QoQ from 9 to 12 employees.
Tulsi Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tulsi Therapeutics's valuation, stock price, and market status.
Is Tulsi Therapeutics a public or private company?
Tulsi Therapeutics is a private company.
What is the current stock price of Tulsi Therapeutics?
Tulsi Therapeutics is a private company with no public stock price. Caplight tracks Tulsi Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Tulsi Therapeutics worth (valuation)?
Valuation information for Tulsi Therapeutics is not publicly available.
Can I buy Tulsi Therapeutics stock?
Tulsi Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tulsi Therapeutics's last funding round?
Tulsi Therapeutics's most recent funding round was Grant on June 1, 2022.
Who are the main investors in Tulsi Therapeutics?
Key investors in Tulsi Therapeutics include Biotechnology Industry Research Assistance Council, ASPIRE-BioNEST.
Will Tulsi Therapeutics IPO soon?
No public IPO plans have been announced for Tulsi Therapeutics.
How can I track Tulsi Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tulsi Therapeutics's secondary market activity and sign up for updates.